The COVID-19 pandemic exposed the deficiencies of an intellectual property system premised on monopolisation and exclusivity. Intellectual property rights over vaccines allowed wealthier nations to secure privileged access to medicines at the expense of others, contributing to preventable illnesses and deaths globally. At the same time, the pandemic created space for alternative approaches which, although imperfectly implemented or sidelined, now warrant renewed attention as we manage future global health crises … (more)
[Zoya Yasmine, The IPKat, 22 September]
Leave a Reply